Re-treatment of Hepatitis C Infection After Multiple Failures of Direct-Acting Antiviral Therapy

BACKGROUND: Direct-acting antiviral (DAA) therapies for hepatitis C virus (HCV) result in initial cure rates of 95% to 99% and re-treatment cure rates of 95%. Nevertheless, given the sheer magnitude of infected persons, some will ultimately fail multiple DAA therapies, and re-treatment of these pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Fierer, Daniel S, Wyles, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148001/
https://www.ncbi.nlm.nih.gov/pubmed/32296728
http://dx.doi.org/10.1093/ofid/ofaa095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148001/
https://www.ncbi.nlm.nih.gov/pubmed/32296728
http://dx.doi.org/10.1093/ofid/ofaa095

Ejemplares similares